[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337715-105":59,"doc-detail-337715-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","characterization-of-zinc-finger-protein-536-a-neuroendocrine-regulator-using-pan-cancer-analysis","Characterization of zinc finger protein 536 - a neuroendocrine regulator - using pan-cancer analysis","","Zinc finger protein 536 (ZNF536) was investigated to clarify its unclear role in cancer. Using public genomic and epigenomic portals, the study assessed mutation, copy number alteration, DNA methylation, and RNA expression, leveraging TCGA pan-cancer cohorts and immunotherapy datasets for prognosis and pathway and tumor microenvironment analyses. Single-cell RNA data defined ZNF536 sublocalization and co-expression, qPCR validated targets, and methylation data supported enrichment and neuroendocrine marker regulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/characterization-of-zinc-finger-protein-536-a-neuroendocrine-regulator-using-pan-cancer-analysis/337715/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/characterization-of-zinc-finger-protein-536-a-neuroendocrine-regulator-using-pan-cancer-analysis/337715.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biological role of ZNF536 was previously suggested, and what gap remained in cancer research?","Question",{"text":112,"@type":113},"Prior studies suggested ZNF536 was abundant in the central brain and regulated neuronal differentiation. Its role in cancer remained unclear, motivating the pan-cancer investigation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which molecular alterations of ZNF536 were analyzed in this study?",{"text":117,"@type":113},"The study examined ZNF536 mutation, copy number alteration, DNA methylation, and RNA expression using public data portals, with TCGA and immunotherapy pan-cancer cohorts.",{"name":119,"@type":110,"acceptedAnswer":120},"How did ZNF536 alterations relate to prognosis and tumor biology across cancers?",{"text":121,"@type":113},"Genetic alterations were frequent and could co-occur within a sample. ZNF536 mutation and amplification showed opposite prognostic patterns in the SU2C-MARK LUAD cohort, and ZNF536 impacted signaling pathways and the tumor microenvironment differently between alteration types.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337715,1791073428,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Zeng et al. European Journal  \nEuropean Journal of Medical Research (2024) 29:273  \n[https://doi.org/10.1186/s40001-024-01792-w](https://doi.org/10.1186/s40001-024-01792-w of Medical Research)[ of Medical Research](https://doi.org/10.1186/s40001-024-01792-w of Medical Research)  \n RESEARCH Open Access  \nCharacterization of zinc finger protein 536,   a neuroendocrine regulator, using pan-cancer analysis  \nLongjin Zeng1†, Longyao Zhang2†, Chenrui Yin2, Xu Chen3, Xiewan Chen1, Lingyou Sun2 and Jianguo Sun2*  \nAbstract  \nBackground Previous studies suggested that zinc finger protein 536 (ZNF536) was abundant in the central brain and regulated neuronal differentiation. However, the role of ZNF536 in cancer has remained unclear.  \nMethods ZNF536 mutation, copy number alteration, DNA methylation, and RNA expression were explored using public portals. Data from The Cancer Genome Atlas (TCGA) were utilized to analyze pathways and tumor microenvironment (TME), with a focus on prognosis in both TCGA and immunotherapy pan-cancer cohorts. Methylated ZNF536 from small cell lung cancer (SCLC) cell lines were utilized to train with probes for conducting enrichment analysis. Single-cell RNA profile demonstrated the sublocalization and co-expression of ZNF536, and validated its targets by qPCR.  \nResults Genetic alterations in ZNF536 were found to be high-frequency and a single sample could harbor different variations. ZNF536 at chromosome 19q12 exerted a bypass effect on CCNE1, supported by CRISPR data. For lung cancer, ZNF536 mutation was associated with longer survival in primary lung adenocarcinoma (LUAD), but its prognosis was poor in metastatic LUAD and SCLC. Importantly, ZNF536 mutation and amplification had opposite prognoses in Stand Up To Cancer-Mark Foundation (SU2C-MARK) LUAD cohort. ZNF536 mutation altered the patterns of genomic alterations in tumors, and had distinct impacts on the signaling pathways and TME compared to ZNF536 amplification. Additionally, ZNF536 expression was predominantly in endocrine tumors and brain tissues. Highdimensional analysis supported this finding and further revealed regulators of ZNF536 . Considering that the methylation of ZNF536 was involved in the synaptic pathway associated with neuroendocrine neoplasms, demonstrating both diagnostic and prognostic value. Moreover, we experimentally verified ZNF536 upregulated neuroendocrine markers.  \nConclusions Our results showed that ZNF536 alterations in cancer, including variations in copy number, mutation, and methylation. We proved the involvement of ZNF536 in neuroendocrine regulation, and identified highly altered ZNF536 as a potential biomarker for immunotherapy.  \nKeywords ZNF536, 19q12 amplification, Mutation, DNA methylation, RNA expression  \n†Longjin Zeng and Longyao Zhang contributed equally to this study.  \n*Correspondence: Jianguo Sun [sunjg09@aliyun.com](sunjg09@aliyun.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Ded","cbCaig0O5Lkl9r1O","https://ap.wps.com/l/cbCaig0O5Lkl9r1O","pdf",4313183,12,"English","# Abstract\n# Introduction\n# Methods\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"What biological role of ZNF536 was previously suggested, and what gap remained in cancer research?\",\"answer\":\"Prior studies suggested ZNF536 was abundant in the central brain and regulated neuronal differentiation. Its role in cancer remained unclear, motivating the pan-cancer investigation.\"},{\"question\":\"Which molecular alterations of ZNF536 were analyzed in this study?\",\"answer\":\"The study examined ZNF536 mutation, copy number alteration, DNA methylation, and RNA expression using public data portals, with TCGA and immunotherapy pan-cancer cohorts.\"},{\"question\":\"How did ZNF536 alterations relate to prognosis and tumor biology across cancers?\",\"answer\":\"Genetic alterations were frequent and could co-occur within a sample. ZNF536 mutation and amplification showed opposite prognostic patterns in the SU2C-MARK LUAD cohort, and ZNF536 impacted signaling pathways and the tumor microenvironment differently between alteration types.\"}]","Characterization of zinc finger protein 536 - a neuroendocrine regulator - using pan-cancer analysis | PDF",1790020308,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a525699f574a480bf2cf9c9c09fa0d9b.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c50a866bba6b14b983c978f7ad140013.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/90a28c9fb83654d7a4960265cf27a590.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9240c0a3b1d5cd0799255a23b3feb4d9.webp",980,1301]